However, there was no significant difference in GFAP+ area between iNSC treated and non-treated treated groups suggesting that iNSC treatment does not have an effect on astrogliosis after stroke at the lesion border (Fig. 6I–L). The gene discussed is GFAP; the disease is stroke disorder.